<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02732509</url>
  </required_header>
  <id_info>
    <org_study_id>16-000437</org_study_id>
    <nct_id>NCT02732509</nct_id>
  </id_info>
  <brief_title>Chronic Inflammation and Exercise Responsiveness</brief_title>
  <official_title>Chronic Inflammation and Exercise Responsiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how chronic inflammation influences skeletal muscle&#xD;
      protein metabolism and metabolic function in humans. The investigators will evaluate acute&#xD;
      responsiveness to a single bout of exercise in men and women who are either lean or&#xD;
      overweight/obese. The investigators will explore the relationship between circulating&#xD;
      inflammatory markers and anabolic, proteomic, and transcriptional responses to acute&#xD;
      exercise. The investigators will measure skeletal muscle protein synthesis in the&#xD;
      postabsorptive state and in response to a single bout of exercise.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal oxygen consumption rates in mitochondria isolated from skeletal muscles</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Lean</arm_group_label>
    <description>Body mass index less than 25 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overweight/obese</arm_group_label>
    <description>Body mass index 25-45 kg/m2</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Men and women between the ages of 30-55 years will be recruited for this study. Fifteen&#xD;
        individuals will be lean, defined as a body mass index (BMI) between 19 and 24 kg/m2.&#xD;
        Thirty individuals will be overweight/obese, defined as a BMI between 25 and 45 kg/m2.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 30-55 years&#xD;
&#xD;
          -  BMI 19-45 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anemia (female subjects hemoglobin of &lt;11 g/dl and male subjects hemoglobin &lt;12 g/dl)&#xD;
&#xD;
          -  Active coronary artery disease or history of unstable macrovascular disease (unstable&#xD;
             angina, myocardial infarction, stroke, and revascularization of coronary, peripheral&#xD;
             or carotid artery within 3 months of recruitment)&#xD;
&#xD;
          -  Renal insufficiency/failure (serum creatinine &gt; 1.5mg/dl)&#xD;
&#xD;
          -  Oral warfarin group medications or history of blood clotting disorders.&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Alcohol consumption greater than 2 glasses/day or other substance abuse&#xD;
&#xD;
          -  Untreated or uncontrolled thyroid disorders&#xD;
&#xD;
          -  Debilitating chronic disease (at the discretion of the investigators)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ian R Lanza, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>March 22, 2016</study_first_submitted>
  <study_first_submitted_qc>April 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2016</study_first_posted>
  <last_update_submitted>January 5, 2021</last_update_submitted>
  <last_update_submitted_qc>January 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Ian R. Lanza</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

